Table 3 Details of the surgical procedures with complete resection and postoperative 30-day complications (Clavien–Dindo classification)

Chemotherapy before surgery for platinum-resistant recurrence

7(35.0%)

Surgical approach

  Laparotomy

9(45.0%)

  Laparoscope

10(50.0%)

  Transvaginal operation

1(5.0%)

Procedure performed (some patients underwent more than 1 procedure)

 Peritonectomy

  Douglas nodule resection

5(25.0%)

  Pelvic wall nodule resection

3(15.0%)

  Pararectal nodule resection

2(10.0%)

  Vaginal stump mass resection

1(5.0%)

  Paravesical nodule resection

1(5.0%)

  Hepatorenal recess nodule resection

1(5.0%)

  Paracolic gutter nodule resection

1(5.0%)

  Hepatic capsule nodule resection

1(5.0%)

  Periureteral nodule resection

1(5.0%)

  Presacral nodule resection

1(5.0%)

  Partial vaginectomy+partial vaginal wall resection

1(5.0%)

  Retroperitoneal mass resection

1(5.0%)

  Diaphragmatic peritonectomy

1(5.0%)

  Iliac paravascular nodule resection

1(5.0%)

  Pelvic peritonectomy

2(10.0%)

  Intestinal surface nodule resection

2(10.0%)

  Mesenteric nodule excision

2(10.0%)

  Intestinal resection (Intestinal anastomosis)

2(10.0%)

 Lymphadenectomy

  Hepatoceliac lymphadenectomy

2(10.0%)

  Pelvic lymphadenectomy

1(5.0%)

  Inguinal and pelvic and para-aortic lymphadenectomy

1(5.0%)

 Parenchymatectomy

  Partial hepatic resection

1(5.0%)

  Splenectomy

1(5.0%)

Median surgical time (minutes, range)

128(45-330)

Intraoperative blood loss (ml, range)

250(10-1800)

Intraoperative transfusion

6(30.0%)

Postoperative transfusion

1(5.0%)

Median hospitalization (days, range)

10(5-33)

Admission to ICU

1(5.0%)

Postoperative complications (some patients underwent more than 1 complication, grade)

  Infection (II)

2(10.0%)

  Anaemia (II)

2(10.0%)

  Ureterectasia (III)

1(5.0%)

  Postoperative ileus (III)

1(5.0%)

  Acute severe pneumonia (III)

1(5.0%)